|
|
|
|
| LEADER |
01384cam a22003014a 4500 |
| 020 |
|
|
|a 9781607950417
|
| 082 |
0 |
0 |
|a R 616.994 061
|b Q0
|
| 100 |
1 |
|
|a Cassileth, Barrie R.
|9 1613
|
| 245 |
1 |
0 |
|a Herb-drug interactions in oncology /
|c Barrie R. Cassileth, K. Simon Yeung and Jyothirmai Gubili.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Connecticut:
|b People's Medical Publishing House-USA,
|c 2010.
|
| 300 |
|
|
|a xvi, 769 p. :
|b col. ill. ;
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Cancer-Alternative treatment-Handbooks, manuals, etc.
|9 1614
|
| 650 |
|
0 |
|a Herbs-Toxicology-Handbooks, manuals, etc.
|9 1615
|
| 650 |
|
0 |
|a Dietary supplements-Toxicology-Handbooks, manuals, etc.
|9 1616
|
| 650 |
|
0 |
|a Drug-herb interactions-Handbooks, manuals, etc.
|9 1617
|
| 650 |
|
0 |
|a Drug-nutrient interactions-Handbooks, manuals, etc.
|9 1618
|
| 650 |
1 |
2 |
|a Herb-Drug Interactions.
|9 1619
|
| 650 |
2 |
2 |
|a Antineoplastic agents, Phytogenic-Adverse effects
|9 1620
|
| 650 |
2 |
2 |
|a Antineoplastic Agents, Phytogenic-Pharmacokinetics
|9 1621
|
| 650 |
2 |
2 |
|a Neoplasms-Drug therapy
|9 1622
|
| 650 |
2 |
2 |
|a Plants, Medicinal-Adverse effects
|9 1623
|
| 700 |
1 |
|
|a Yeung, K. Simon.
|9 1624
|
| 700 |
1 |
|
|a Jyothirmai Gubili.
|9 1625
|
| 942 |
|
|
|c BK
|
| 999 |
|
|
|c 50824
|d 50824
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 616_994000000000000_061_Q0
|7 0
|9 51556
|a MGUL
|b MGUL
|d 2013-07-16
|e EUR79.95
|l 0
|o 616.994 061 Q0
|p 48824
|r 2013-07-16
|w 2013-07-16
|y BK
|